Construction and characterization of rhesus monkey rotavirus (MMU18006)- or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines

Vaccine

Volumn 21, Issue 21-22, 2003, Pages 3003-3010

  Hoshino, Yasutaka ^a   Jones, Ronald W ^a   Ross, Jerri ^a   Kapikian, Albert Z ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Rotavirus G5, G8, G9 or G10; Rotavirus vaccine; Single VP7 gene substitution reassortant

Indexed keywords

ROTAVIRUS VACCINE; SIMIAN ROTAVIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG SPECIFICITY; DRUG SYNTHESIS; GENETIC CODE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; SEROTYPE; VIRUS STRAIN;

EID: 0038512600     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00120-8     Document Type: Article

References (89)

1. Bern C, Glass RI. Impact of diarrheal diseases worldwide. In: Kapikian AZ, editor. Viral infections of gastrointestinal tract. New York: Marcel Dekker; 1994:1-26.
2. Bresee J.S., Glass R.I., Ivanoff B., Gentsch J.R. Current status and future priorities for rotavirus vaccine development. Vaccine. 17:1999;2207-2222.
3. Kapikian AZ, Hoshino Y, Chanock RM. Rotaviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb PA, Martin MA, Roizman B, Straus SE, editors. Fields virology, 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001:1787-833.
4. Glass R.I., Gentsch J., Smith J.C. Rotavirus vaccines: success by reassortment? Science. 265:1994;1389-1391.
5. Bishop R.F., Barnes G.L., Cipriani E., Lund J.S. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. New Engl. J. Med. 309:1983;72-76.
6. Fischer T.K., Valentiner-Branth P., Steinsland H. Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea - Bissau, West Africa. J. Infect Dis. 186:2002;593-597.
7. Velazquez F.R., Matson D.O., Calva J.J.et al. Rotavirus infection in infants as protection against subsequent infections. New Engl. J. Med. 335:1996;1022-1028.
8. Wyatt R.G., Mebus C.A., Yolken R.H.et al. Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus. Science. 203:1979;548-550.
9. Advisory Committee on Immunization Practices. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. MMWR Morb Mortal Weekly Rep 1999;48:1-23.
10. CDC. Intussusception among recipients of rotavirus vaccine - United States, 1998-1999. MMWR Morb Mortal Weekly Rep 1999;48:577-81.
11. CDC. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Weekly Rep 1999;48:1007.
12. Kapikian A.Z. A rotavirus vaccine for prevention of severe diarrhea of infants and young children: development, utilization and withdrawal. Novartis Found. Symp. 238:2001;153-179.
13. Murphy T.V., Gargiullo P.M., Massoudi M.S. Intussusception among infants given an oral rotavirus vaccine. New Engl. J. Med. 344:2001;564-572.
14. Kramarz P., France E.K., Destefano F.et al. Population-based study of rotavirus vaccination and intussusception. Pediatr. Infect. Dis. J. 20:2001;410-416.
15. Simonsen L., Morens D., Elixhauser A.et al. Effect of rotavirus vaccination program on trends in admission of infants to hospital for intussusception. Lancet. 18:2001;5-14.
16. Midthun K., Greenberg H.B., Hoshino Y., Kapikian A.Z., Wyatt R.G., Chanock R.M. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 53:1985;949-954.
17. Midthun K., Hoshino Y., Kapikian A.Z., Chanock R.M. Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. J. Clin. Microbiol. 24:1986;822-826.
18. Gentsch J.R., Woods P.A., Ramachandran M.et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J. Infect. Dis. 174(Suppl):1996;S30-S36.
19. Hoshino Y., Kapikian A.Z. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development. J. Health Popul. Nutr. 18:2000;5-14.
20. Koshimura Y., Nakagomi T., Nakagomi O. The relative frequencies of G serotypes of rotaviruses recovered from hospitalized children with diarrhea: A 10-year survey (1987-1996) in Japan with a review of globally collected data. Microbiol. Immunol. 44:2000;499-510.
21. Clements-Mann M.L., Makhene M.K., Mrukowicz J.et al. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine. 17:1999;2715-2725.
22. Clements-Mann M.L., Dudas R., Hoshino Y.et al. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Vaccine. 19:2001;4676-4684.
23. Offit P.A. The future of rotavirus vaccines. Seminars Pediatr. Infect. Dis. 13:2002;190-195.
24. Hoshino Y., Jones R.W., Chanock R.M., Kapikian A.Z. Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK. Vaccine. 20:2002;3576-3584.
25. Adah M.I., Rohwedder A., Olaleyly O.D., Werchau H. Nigerian rotavirus serotype G8 could not be typed by PCR due to nucleotide mutation at the 3′ end of the primer binding site. Arch. Virol. 142:1997;1881-1887.
26. Aijaz S., Gowda K., Jagannath H.V.et al. Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup ad serotype analysis. Arch. Virol. 141:1996;715-726.
27. Armah G.E., Pager C.T., Asmah R.H.et al. Prevalence of unusual human rotavirus strains in Ghananian children. J. Med. Virol. 63:2001;67-71.
28. Beards G., Xu L., Ballard A., Desselberger U., McCrae M.A. A serotype 10 human rotavirus. J. Clin. Microbiol. 30:1992;1432-1435.
29. Bishop R.F., Masendycz P.J., Bugg H.C., Carlin J.B., Barnes G.L. Epidemiological patterns of rotaviruses causing severe gastroenteritis in young children throughout Australia from 1993 to 1996. J. Clin. Microbiol. 39:2001;1085-1091.
30. Bok K., Castagnaro N., Borsa A.et al. Surveillance for rotavirus in Argentina. J. Med. Virol. 65:2001;190-198.
31. Coluchi N., Munford V., Manzur J.et al. Detection, subgroup specificity, and genotype diversity of rotavirus strains in children with acute diarrhea in Paraguay. J. Clin. Microbiol. 40:2002;1709-1714.
32. Cunliffe N.A., Gondwe J.S., Robin L.et al. Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6] G8 strains. J. Med. Virol. 57:1999;308-312.
33. Cunliffe N.A., Gondwe J.S., Graham S.M.et al. Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J. Clin. Microbiol. 39:2001;836-843.
34. Dunn S.J., Greenberg H.B., Ward R.L.et al. Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J. Clin. Microbiol. 31:1993;165-169.
35. Gouvea V., de Castro L., Timenetsky M.C.S.T., Greenberg H.B., Santos N. Rotavirus serotype G5 associated with diarrhea in Brazilian children. J. Clin. Microbiol. 32:1994;1408-1409.
36. Holmes J.L., Kirkwood C.D., Gerna G.et al. Characterization of unusual G8 rotavirus strains isolated from Egyptian children. Arch. Virol. 144:1999;1381-1396.
37. Jagannath M.R., Vethanayagam R.R., Yugandhar Reddy B.S., Raman S., Durga Rao C. Characterization of human symptomatic rotavirus isolates, from Mysore, India, MP409 and MP480 having 'long' RNA electropherotype and subgroup I specificity, highly related to the P6[1], G8 type bovine rotavirus A5. Arch. Virol. 145:2000;1339-1357.
38. Kelkar S.D., Ayachit V.L. Circulation of group A rotavirus subgroups and serotypes in Pune, India, 1990-1997. J. Health Popul. Nutr. 18:2000;163-170.
39. Leite J.P., Alfieri A.A., Woods P.A., Glass R.I., Gentsch J.R. Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis. Arch. Virol. 141:1996;2365-2374.
40. Nakata S., Gatheru Z., Ukae S.et al. Epidemiological study of the G serotype distribution of group A rotaviruses in Kenya from 1991 to 1994. J. Med. Virol. 58:1999;296-303.
41. O'Halloran F., Lynch M., Cryan B., O'Shea H., Fanning S. Molecular characterization of rotavirus in Ireland: detection of novel strains circulating in the population. J. Clin. Microbiol. 38:2000;3370-3374.
42. Palombo E., Clark R., Bishop R.F. Characterization of a "European-like" serotype G8 human rotavirus isolated in Australia. J. Med. Virol. 60:2000;56-62.
43. Steele A.D., Parker S.P., Peenze I., Pager C.T., Taylor M.B., Cubitt W.D. Comparative studies of human rotavirus serotype G8 strains recovered in South Africa and the United Kingdom. J. Gen. Virol. 80:1999;3029-3034.
44. Urasawa S., Hasegawa A., Urasawa T.et al. Antigenic and genetic analyses of human rotaviruses in Chiang Mai, Thailand: evidence for a close relationship between human and animal rotaviruses. J. Infect. Dis. 166:1992;227-234.
45. Araújo I.T., Ferreira M.S.R., Fialho M.A.et al. Rotavirus genotypes P[4] G9, P[6] G9, and P[8] G9 in hospitalized children with acute gastroenteritis in Rio de Janeiro, Brazil. J. Clin. Microbiol. 39:2001;1999-2001.
46. Bon F., Fromantin C., Aho S., Pothier P., Kohli E. G and P genotyping of rotavirus strains circulating in France over a 3-year period: detection of G9 and P[6] strains at low frequencies. J. Clin. Microbiol. 38:2000;1681-1683.
47. Cubitt W.D., Steele A.D., Iturriza M. Characterization of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9 P2A[6] and G3 P2A[6]. J. Med. Virol. 61:2000;50-54.
48. Griffin D.D., Kirkwood C.D., Parashar U.D.et al. Surveillance of rotavirus strains in the United States: identification of unusual strains. The National Rotavirus Strain Surveillance System collaborating laboratories. J. Clin. Microbiol. 38:2000;2784-2787.
49. Iturriza-Gomara M., Cubitt D., Steele D. Characterization of rotavirus G9 strains isolated in the UK between 1995 and 1998. J. Med. Virol. 61:2000;510-517.
50. Maneekarn N., Ushijima H. Epidemiology of rotavirus infection in Thailand. Pediatr. Int. 42:2000;415-421.
51. Masendycz P., Bogdanovic-Sakran N., Palombo E., Bishop R., Barnes G. Annual report of the Rotavirus Surveillance Programme 1999-2000. Commun. Dis. Intell. 24:2000;195-198.
52. Oka T., Nakagomi T., Nakagomi O. Apparent re-emergence of serotype G9 in 1995 among rotaviruses recovered from Japanese children hospitalized with acute gastroenteritis. Microbiol. Immunol. 44:2000;957-961.
53. Palombo E.A., Masendycz P.J., Bugg H.C.et al. Emergence of serotype G9 human rotaviruses in Australia. J. Clin. Microbiol. 38:2000;1305-1306.
54. Ramachandran M., Das B.K., Vij A.et al. Unusual diversity of human rotavirus G and P genotypes in India. J. Clin. Microbiol. 34:1996;436-439.
55. Ramachandran M., Gentsch J.R., Parashar U.D.et al. Detection and characterization of novel rotavirus strains in the United States. J. Clin. Microbiol. 36:1998;3223-3229.
56. Rosa e Silva M.L., de Carvalho I.P., Gouvea V. 1998-1999 rotavirus seasons in Juiz de Fora, Minas Gerais, Brazil: detection of an unusual G3P[4] epidemic strain. J. Clin. Microbiol. 40:2002;2837-2842.
57. Santos N., Volotao E.M., Soares C.C.et al. Rotavirus strains bearing genotype G9 or P[9] recovered from Brazilian children with diarrhea from 1997 to 1999. J. Clin. Microbiol. 39:2001;1157-1160.
58. Unicomb L.E., Podder G., Gentsch J.R.et al. Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J. Clin. Microbiol. 37:1999;1885-1891.
59. Van Man N., Van Trang N., Phuong H.et al. The epidemiology and disease burden of rotavirus in Vietnam: sentinel surveillance at six hospitals. J. Infect Dis. 183:2001;1707-1712.
60. Widdowson M.A., van Doornum G.J., van der Poel W.H., de Boer A.S., Mahdi U., Koopmans M. Emerging group-A rotavirus and a nosocomial outbreak of diarrhoea. Lancet. 356:2000;1161-1162.
61. Zhou Y., Li L., Kim B.et al. Rotavirus infection in children in Japan. Pediatr. Int. 42:2000;428-439.
62. Timenetsky M.C.S.T., Gouvea V., Santos N., Carmona R.C., Hoshino Y. A novel human rotavirus serotype with dual G5-G11 specificity. J. Gen. Virol. 78:1997;1373-1378.
63. Nakagomi T., Ohshima A., Akatani K., Ikegami N., Katsushima N., Nakagomi O. Isolation and molecular characterization of a serotype 9 human rotavirus strain. Microbiol. Immunol. 34:1990;77-82.
64. Wyatt R.G., Greenberg H.B., James W.D.et al. Definition of human rotavirus serotypes by plaque reduction assay. Infect. Immun. 37:1982;110-115.
65. Greenberg H.B., Valdesuso J., Van Wyke K.et al. Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J. Virol. 47:1983;267-275.
66. Benfield DA, Nelson EA, Hoshino Y. A monoclonal antibody to the Gottfried strain of porcine rotavirus which neutralizes rotavirus serotypes 3, 4, and 6. In: Abstracts of the Seventh International Congress of Virology, Edmonton, Alberta, Canada; 1987. p. 111, R11-9.
67. Snodgrass D.R., Fitzgerald T., Campbell I.et al. Rotavirus serotypes 6 and 10 predominate in cattle. J. Clin. Microbiol. 28:1990;504-507.
68. Taniguchi K., Urasawa T., Morita Y., Greenberg H.B., Urasawa S. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, or 4-specific monoclonal antibodies to VP7. J. Infect. Dis. 155:1987;1159-1166.
69. Jones RW, Ross J, Hoshino Y. Identification of parental origin of cognate dsRNA genome segment(s) of rotavirus reassortants by constant denaturant gel electrophoresis. J Clin Virol; 2003 [in press].
70. Hoshino Y., Jones R.W., Kapikian A.Z. Serotypic characterization of outer capsid spike protein VP4 of vervet monkey rotavirus SA11 strain. Arch. Virol. 143:1998;1233-1244.
71. Bernstein D.I., Glass R.I., Rodgers G.et al. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children: US Rotavirus Vaccine Efficacy Group. JAMA. 273:1995;1191-1196.
72. Rennels M.B., Glass R.I., Dennehy P.H.et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the national multicenter trial: US Rotavirus Vaccine Efficacy Group. Pediatrics. 97:1996;7-13.
73. Joensuu J., Koskenniemi E., Pang X.L., Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 350:1997;1205-1209.
74. Santosham M., Letson G.W., Wolff M.et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in native American populations. J. Pediatr. 131:1997;632-638.
75. Joensuu J., Koskenniemi E., Vesikari T. Prolonged efficacy of rhesus-human reassortant rotavirus vaccine. Pediatr. Infect. Dis. J. 17:1998;427-429.
76. Perez-Schael I., Guntinas M.J., Perez M.et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. New Engl. J. Med. 337:1997;1181-1187.
77. Bresee J., Arifeen S., Azim T.et al. Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh. Pediatr. Infect. Dis. J. 20:2001;1136-1143.
78. Jiang B., Gentsch J.R., Glass R.I. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin. Infect. Dis. 15:2002;1351-1361.
79. Markwick A.J., Rennels M.B., Zito E.T.et al. Oral tetravalent rotavirus vaccine can be successfully co-administered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. Pediatr. Infect. Dis. J. 17:1998;913-918.
80. Hoshino Y., Saif L.J., Kang S.-Y., Sereno M.M., Chen W.-K., Kapikian A.Z. Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology. 209:1995;274-280.
81. Stuker G., Oshiro L., Schmidt N.J. Antigenic comparisons of two new rotaviruses from rhesus monkey. J. Clin. Microbiol. 11:1980;202-203.
82. Wyatt R.G., James H.D. Jr., Pittman A.L.et al. Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J. Clin. Microbiol. 18:1983;310-317.
83. Bohl E.H., Theil K.W., Saif L.J. Isolation and serotyping of porcine rotaviruses and antigenic comparison with other rotaviruses. J. Clin. Microbiol. 19:1984;105-111.
84. Gerna G., Sarasini A., Parea M.et al. Isolation and characterization of two distinct human rotavirus strains with G6 specificity. J. Clin. Microbiol. 30:1992;9-16.
85. Woode G.N., Jones J., Bridger J. Levels of colostral antibodies against neonatal calf diarrhea virus. Vet. Rec. 97:1975;148-149.
86. Matsuno S., Hasegawa A., Mukoyama A., Inouye S. A candidate for a new serotype of human rotavirus. J. Virol. 54:1985;623-624.
87. Gerna G., Sarasini A., Zentilin L.et al. Isolation in Europe of 69M-like (serotype 8) human rotavirus strains with either subgroup I or II specificity and a long RNA electropherotype. Arch. Virol. 112:1990;27-40.
88. Clark H.F., Hoshino Y., Bell L.M.et al. Rotavirus WI61 representing a presumptive new human serotype. J. Clin. Microbiol. 25:1987;1757-1762.
89. Urasawa S., Urasawa T., Wakasugi F.et al. Presumptive seventh serotype of human rotavirus. Arch. Virol. 113:1990;279-282.